Mixed-method Evaluation of a Parental Psychoeducation Programme in a Suicide Risk Prevention Group
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Aug 26, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program designed to help parents understand and support their children who are at risk of suicide. Since the number of young people experiencing suicidal thoughts or attempts has been increasing, this program aims to provide parents with the tools and knowledge they need to better help their kids. The program consists of four sessions where parents can learn about suicide prevention and share their experiences with others in similar situations.
To participate in this trial, parents must have a child under 15 years old who has shown suicidal thoughts or attempts, and they need to be comfortable speaking French. Unfortunately, parents who are not part of a health insurance plan or who are under legal guardianship cannot join. Those who take part can expect to engage in discussions, learn valuable information, and contribute to improving this important program for other families in the future. Your involvement could help shape better support for parents and children facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent committing to participate in the 4 sessions of the parental psychoeducation prevention program suicide risk (PEPPS program)
- • Parents of children under 15 years and 6 months
- • Parents fluent in French
- Exclusion Criteria:
- • Lack of affiliation with a social security scheme or CMU (universal health coverage)
- • Parents under guardianship or curatorship
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Ile De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported